Nabriva Therapeutics PLC logo

Nabriva Therapeutics PLC (NBRVF)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
323 Market Cap
- P/E Ratio
- Div Yield
780 Volume
- Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track NBRVF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
1 Apr 2026
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
15 Apr 2024
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
27 Mar 2024
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
13 Oct 2023
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
16 Nov 2016
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
9 Aug 2016
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
27 Apr 2016
-
-
Nabriva Therapeutics PLC logo
NBRVF Nabriva Therapeutics PLC
11 Nov 2015
-
-

NBRVF Earnings Reports FAQ

What is the earnings per share (EPS) for NBRVF?

EPS data for NBRVF is currently not available, as Nabriva Therapeutics PLC has not reported recent earnings.

What is the company's earnings growth rate?

Nabriva Therapeutics PLC has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Nabriva Therapeutics PLC has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Nabriva Therapeutics PLC are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for NBRVF at this time, as Nabriva Therapeutics PLC has no recent EPS data to calculate it.